David Malcom Rodman's Net Worth

$4.12 Million

Estimate Recalculated Nov 11, 2024 01:47PM EST

Who is David Malcom Rodman

David Malcom Rodman has an estimated net worth of $4.12 Million. This is based on reported shares across multiple companies, which include Mineralys Therapeutics, Inc., and Nivalis Therapeutics, Inc..

SEC CIK

David Malcom Rodman's CIK is 0001672659

Past Insider Trading and Trends

2024 was David Malcom Rodman's most active year for acquiring shares with 19 total transactions. David Malcom Rodman's most active month to acquire stocks was the month of July. 2024 was David Malcom Rodman's most active year for disposing of shares, totalling 20 transactions. David Malcom Rodman's most active month to dispose stocks was the month of July. 2023 saw David Malcom Rodman paying a total of $177,102.18 for 375,971 shares, this is the most they've acquired in one year. In 2023 David Malcom Rodman cashed out on 483,501 shares for a total of $2,994,400.71, their largest year based on trade value.

Loading...

Attention insiders:Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Mineralys Therapeutics, Inc.

Chief Medical Officer
Updated Nov 08, 2024
Form 4
-8.45%
-25.48K
$8.06
-$355.55K
Nov 08, 2024
275.93K
Sale
ScheduledNov 06
Form 4
$0.82
$8.49K
Oct 15, 2024
316.46K
Options
Oct 11 - Oct 14
Form 4
$0.84
$9.57K
Sep 12, 2024
316.46K
Options
Sep 11 - Sep 12
Form 4
$0.84
$9.57K
Aug 13, 2024
316.46K
Options
Aug 12
Form 4
-0.18%
-525.00
$8.04
-$7.31K
Jul 18, 2024
286.36K
Sale
ScheduledJul 16
Form 4
$0.84
$9.57K
Jul 12, 2024
316.99K
Options
Jul 11 - Jul 12
Form 4
$0.84
$9.57K
Jun 13, 2024
315.21K
Options
Jun 11 - Jun 12
Form 4
$0.84
$9.57K
May 15, 2024
315.21K
Options
May 13
Form 4
-0.04%
-100.00
$8.04
-$1.39K
May 10, 2024
270.05K
Sale
ScheduledMay 09
Form 4
$0.84
$9.57K
Apr 15, 2024
315.31K
Options
Apr 11 - Apr 12
Form 4
$0.84
$9.57K
Mar 13, 2024
315.31K
Options
Mar 11 - Mar 12
Form 4
200.00K
Feb 15, 2024
200.00K
Grant
Feb 13
Form 4
$0.84
$9.57K
Feb 13, 2024
315.31K
Options
Feb 12
Form 4
$0.84
$9.57K
Jan 12, 2024
315.31K
Options
Jan 11 - Jan 12
Form 4
$0.54
$2.71K
Dec 12, 2023
85.29K
Options
Dec 11
Form 4
$0.54
$2.71K
Nov 14, 2023
85.29K
Options
Nov 13
Form 4
$0.54
$5.42K
Nov 07, 2023
85.29K
Options
Nov 03
Form 4
-42.47%
-231.72K
$6.82
-$2.83M
Aug 11, 2023
313.84K
Sale
Aug 10 - Aug 11
Form 4
20.00K
Mar 21, 2023
20.00K
Grant
Mar 17
Form 4
104.19K
Feb 13, 2023
104.19K
Grant
Feb 09
Form 3
Feb 09, 2023
Showing 21 results

Nivalis Therapeutics, Inc.

Exec Vice President and CMO
Updated Jan 05, 2017
Form 4
-3.70%
-6.69K
$2.27
-$15.18K
Jan 05, 2017
173.87K
Sale
ScheduledJan 03 - Jan 04
Form 4
-2.93%
-5.82K
$7.96
-$46.33K
Oct 05, 2016
192.79K
Sale
ScheduledOct 03 - Oct 04
Form 4
100.00K
Sep 14, 2016
100.00K
Grant
Sep 12
Form 4
-2.75%
-5.95K
$4.66
-$27.73K
Jul 06, 2016
210.72K
Sale
ScheduledJul 01 - Jul 05
Form 3
Apr 22, 2016
Showing 5 results